1. Germany Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Bayer AG

Bayer AG

BAY.WA
Bayer AGPL flagWarsaw Stock Exchange
144.90
PLN
+2.05
- -
142.35BMarket Cap

Total Valuation

Bayer AG carries a market capitalization of 142.35B, placing it among publicly traded companies globally. Its enterprise value stands at 31.70B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap142.35B
Enterprise Value31.70B

Share Statistics

Bayer AG currently has 982.42M shares outstanding.

Shares Outstanding982.42M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.85, and the price-to-book ratio stands at 15.21.

PE RatioN/A
PS Ratio0.85
PB Ratio15.21
P/TBV Ratio-1.92
P/FCF Ratio4.99
P/OCF Ratio7.42

Enterprise Valuation

On an enterprise value basis, Bayer AG trades at an EV/EBITDA multiple of 4.32 and an EV/FCF ratio of 3.21. The EV/Sales ratio of 0.70 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.32 provides insight into valuation relative to core operating earnings.

EV / Sales0.70
EV / EBITDA4.32
EV / EBIT4.32
EV / FCF3.21

Financial Position

Bayer AG maintains a current ratio of 1.06, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

Current Ratio1.06
Quick Ratio0.20
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage3.58

Financial Efficiency

Return on Equity (ROE)-85.73
Return on Assets (ROA)-1.99
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)25.88
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.49

Taxes

Over the trailing twelve months, Bayer AG has paid 162.00M in income taxes, reflecting an effective tax rate of 7.43.

Income Tax162.00M
Effective Tax Rate7.43

Stock Price Statistics

Bayer AG's stock has gained approximately 34.96647% over the past 52 weeks. The 50-day moving average sits at 165.61, while the 200-day moving average is 149.86.

Beta (5Y)N/A
52-Week Price Change34.96647%
50-Day Moving Average165.61
200-Day Moving Average149.86
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Bayer AG generated 45.24B in revenue and converted that into -2.16B in net income, yielding earnings per share of -2.17. EBITDA reached 7.34B, while operating income came in at 7.34B.

Revenue45.24B
Gross Profit26.84B
Operating Income7.34B
Pretax Income-1.97B
Net Income-2.16B
EBITDA7.34B
EBIT7.34B
Earnings Per Share (EPS)-2.17

Balance Sheet

Total book value stands at 2.52B, with working capital of 1.84B providing operational flexibility.

Cash & Cash Equivalents6.66B
Total DebtN/A
Net Debt-5.73B
Equity (Book Value)2.52B
Book Value Per Share2.56
Working Capital1.84B

Cash Flow

Bayer AG produced 5.15B in operating cash flow over the past twelve months. After subtracting -2.51B in capital expenditures, free cash flow totaled 2.64B - equivalent to 2.69 per share.

Operating Cash Flow5.15B
Capital Expenditures-2.51B
Free Cash Flow2.64B
FCF Per Share2.69

Margins

Bayer AG operates with a gross margin of 59.32, reflecting its pricing power and cost economics. The operating margin of 16.23 and net profit margin of -4.77 provide insight into operational efficiency.

Gross Margin59.32
Operating Margin16.23
Pretax Margin-4.35
Profit Margin-4.77
EBITDA Margin16.23

Dividends & Yields

The company's payout ratio of -6.02 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.13
Dividend YieldN/A
Payout Ratio-6.02
Shareholder Yield5.53
FCF Yield20.03

Scores

Bayer AG posts an Altman Z-Score of 1.50, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.50